Testosterone is often thought of as exclusively a male hormone, but women produce and require it too — in much smaller amounts. For women dealing with low libido, fatigue, or menopausal symptoms that other treatments have not resolved, testosterone replacement therapy for women has become an increasingly studied and medically supported option. Here is a complete, evidence-based look at what it offers, what it risks, and who it is genuinely appropriate for.
Why Women Need Testosterone Too
Testosterone is produced in women primarily by the ovaries and adrenal glands, circulating at levels roughly one-tenth to one-twentieth of typical male levels. Despite the smaller amount, it plays meaningful roles in:
- Sexual desire, arousal, and satisfaction
- Energy and overall vitality
- Bone density maintenance
- Muscle mass and strength
- Mood regulation and sense of wellbeing
Testosterone levels in women decline gradually with age and drop more significantly after surgical removal of the ovaries or natural menopause — which is why interest in supplementation often arises during midlife.
The Primary Approved Use: Hypoactive Sexual Desire Disorder
The strongest evidence base for testosterone therapy in women relates to Hypoactive Sexual Desire Disorder (HSDD) — a clinically recognized condition involving persistent, distressing loss of sexual desire not explained by other medical or relationship factors.
Multiple randomized controlled trials reviewed by the Endocrine Society have demonstrated that testosterone therapy improves sexual desire, arousal, and satisfaction in postmenopausal women with confirmed HSDD when other contributing factors have been addressed first.
Other Potential Benefits Being Studied
Beyond HSDD, researchers continue exploring testosterone’s role in women’s health for:
- Menopausal fatigue and low energy — evidence is less robust than for sexual function but some women report meaningful improvement
- Mood and overall wellbeing — particularly in women whose mood symptoms correlate with documented low testosterone
- Bone density support — testosterone contributes to bone health alongside estrogen, though this is not a primary indication for therapy
- Cognitive function — early research exists but is not yet conclusive enough to support this as a standalone treatment goal
It is important to note these additional benefits remain under research and are not the primary FDA-recognized clinical indication. Treatment decisions should center on documented symptoms — particularly HSDD — rather than general wellness goals.
Benefits Women Commonly Report
When testosterone therapy is appropriately dosed and monitored, women frequently report:
- Increased sexual desire and responsiveness
- Improved energy levels
- Better mood and motivation
- Increased sense of overall vitality
- Some improvement in muscle tone with concurrent exercise
Risks and Side Effects
Testosterone therapy for women requires careful dosing precisely because the therapeutic window is narrower than in men — too much testosterone produces masculinizing side effects relatively quickly at female-appropriate hormone levels.
| Side Effect | Likelihood | Notes |
|---|---|---|
| Acne | Common | Usually mild, dose-related |
| Increased facial/body hair | Common at higher doses | Most distressing reported side effect |
| Voice deepening | Uncommon at proper doses | Can be irreversible if it occurs |
| Clitoral enlargement | Possible | Dose-dependent, monitored closely |
| Scalp hair thinning | Less common | Occurs in genetically predisposed women |
| Mood changes | Variable | Can go either direction |
| Cholesterol/lipid changes | Possible | Monitored through bloodwork |
A complete breakdown of these effects is covered in female TRT side effects in greater depth.
How Female TRT Differs From Male TRT
| Factor | Female TRT | Male TRT |
|---|---|---|
| Target testosterone level | Female physiological range | Male physiological range (400–900 ng/dL) |
| Dose | Roughly 1/10th of male doses | Standard therapeutic male doses |
| FDA-approved product | None currently in the U.S. | Multiple approved formulations |
| Formulation source | Compounded or off-label male products | FDA-approved pharmaceutical products |
| Primary clinical indication | HSDD | Confirmed hypogonadism |
The absence of an FDA-approved female-specific testosterone product in the United States means treatment typically involves compounded preparations or carefully reduced doses of male-formulated products — making provider experience in this specific area especially important.
Who Is a Good Candidate
Testosterone therapy for women is most appropriate for:
- Postmenopausal women with confirmed HSDD that has not responded to addressing other contributing factors (relationship issues, medication side effects, vaginal atrophy, depression)
- Women with documented low testosterone levels alongside consistent, distressing symptoms
- Women who have had a thorough evaluation ruling out other causes of low libido or fatigue
Who Should Avoid Testosterone Therapy
Testosterone therapy is not appropriate for:
- Women who are pregnant or breastfeeding
- Women with hormone-sensitive cancers without specialist clearance
- Women with undiagnosed abnormal vaginal bleeding
- Premenopausal women without a specific, well-documented clinical indication
- Women seeking treatment for general anti-aging or wellness purposes without a diagnosed condition
Monitoring Requirements
| Marker | Frequency |
|---|---|
| Total and free testosterone | Every 3 months initially, then every 6 months |
| Lipid panel | Every 6–12 months |
| Clinical assessment for androgenic side effects | Every visit |
| Symptom and treatment satisfaction tracking | Ongoing |
Consistent monitoring is what keeps the treatment in the narrow safe and effective range — testosterone therapy for women is not a “set and forget” treatment.
Pricing for Female TRT
- Compounded testosterone cream or gel: $40–$100/month
- Provider consultation and ongoing monitoring: $100–$300 per visit
- Lab testing: $50–$150 per draw
Insurance coverage is inconsistent due to the absence of an FDA-approved product for this specific indication — many women pay out of pocket or use HSA/FSA funds for treatment and monitoring costs.
Talk to a Specialist About Your Symptoms
Testosterone therapy can be genuinely life-changing for women with confirmed HSDD or documented deficiency — but it requires a provider experienced in the nuances of female hormone dosing and monitoring.
Book your consultation today and discuss whether testosterone therapy is appropriate for your specific symptoms and health history.
Frequently Asked Questions
What is testosterone replacement therapy for women primarily used for?
The strongest evidence supports its use for Hypoactive Sexual Desire Disorder (HSDD) in postmenopausal women, though it is also explored for energy and mood support.
Is there an FDA-approved testosterone product for women?
No — currently no FDA-approved testosterone product exists specifically for women in the United States, so treatment typically uses compounded formulations or carefully reduced male-formulated products.
How is the dose different for women compared to men?
Women use doses roughly one-tenth of typical male TRT doses, targeting testosterone levels within the normal female physiological range rather than male range.
What are the biggest risks of TRT for women?
The primary risks are androgenic side effects like acne, increased body hair, and in rare cases, voice changes — all of which are dose-dependent and minimized through careful monitoring.
Can premenopausal women use testosterone therapy?
It is generally not recommended for premenopausal women without a specific, well-documented clinical indication, since evidence and safety data are most established in postmenopausal populations.